Back to calendar
Viridian Therapeutics, Inc. (VRDN) Earnings
VRDN reports earnings on Wednesday, November 4, 2026
earnings report
November 4, 2026
Q3 2026
Est. EPS: $-1.02
Actual EPS: $-1.05
EPS surprise: -1.48%
Company overview
Market Cap$2.5B
PriceUSD 22.37
EPS (TTM)-3.71
52-week high34.29
52-week low13.18
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees252